Clinical trial registry record

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated January 26, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06089083
Last registry update
January 26, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
University of California, San Francisco
Enrollment
500
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
500
Population
FEMALE · 18 Years
Duration
2023-10-18 to 2033-11-30
Intervention
Physical function assessment; Self-reported Assessments and Questionnaires; Surgery (Standard of Care, Non-Interventional)
Comparator
Not reported
Outcomes measured
Proportion of participants who are categorized as frail — At time of enrollment, 1 day; Demographic risk factors associated with those who screen positive for frailty — At time of enrollment, 1 day; Oncologic risk factors associated with those who screen positive for frailty — At time of enrollment, 1 day; Mean number of healthy days at home — Up to 10 years; Mean length of hospital stay — Up to 10 years; Percentage of participants readmitted to hospital — Up to 10 years; Percentage of participants with reported surgical complications — Up to 10 years; Mean time to initiation of standard of care chemotherapy — Up to 10 years; Median Progression Free Survival (PFS) — Up to 10 years; Median Overall Survival (OS) — Up to 10 years; Mean number of treatment delays — Up to 10 years
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

frailty
Open primary sourceExport JSON